Ishigooka M - Search Results

1

Relationship between the shape of passive urethral resistance relation and prostatic histology in patients with benign prostatic hyperplasia.

Ichiyanagi O, Sasagawa I, Suzuki Y, Ishigooka M, Nakada T. Ichiyanagi O, et al. Among authors: ishigooka m. Urol Int. 2002;68(4):243-5. doi: 10.1159/000058443. Urol Int. 2002. PMID: 12053025

2

Serum prostatic acid phosphatase, gamma-seminoprotein and prostatic specific antigen in hemodialysis patients.

Sasagawa I, Nakada T, Hashimoto T, Ishigooka M, Kubota Y, Hirano K, Hirano J, Suzuki Y. Sasagawa I, et al. Among authors: ishigooka m. Urol Int. 1992;48(2):181-3. doi: 10.1159/000282326. Urol Int. 1992. PMID: 1374977

3

Nuclear DNA ploidy pattern and tissue levels of dihydroxyphenylalanine and catecholamines in pheochromocytoma.

Sasagawa I, Nakada T, Kubota Y, Ishigooka M, Sawamura T, Suzuki Y. Sasagawa I, et al. Among authors: ishigooka m. Urol Int. 1995;54(4):181-3. doi: 10.1159/000282720. Urol Int. 1995. PMID: 7610501

4

Renal cell carcinoma in dialysis patients.

Sasagawa I, Nakada T, Kubota Y, Suzuki Y, Ishigooka M, Terasawa Y. Sasagawa I, et al. Among authors: ishigooka m. Urol Int. 1994;53(2):79-81. doi: 10.1159/000282640. Urol Int. 1994. PMID: 7801421

5

Unilateral diffuse adrenal hyperplasia masquerading as aldosterone-producing adenoma in primary hyperaldosteronism.

Sasagawa I, Nakada T, Hashimoto T, Kato T, Suzuki H, Ishigooka M, Kubota Y. Sasagawa I, et al. Among authors: ishigooka m. Urol Int. 1993;50(4):218-22. doi: 10.1159/000282488. Urol Int. 1993. PMID: 8506594

6

Correlation between morphometric differences and norepinephrine content in benign prostatic hyperplasia.

Ishigooka M, Hashimoto T, Hayami S, Suzuki Y, Sasagawa I, Nakada T. Ishigooka M, et al. Prostate. 1996 Jun;28(6):385-91. doi: 10.1002/(SICI)1097-0045(199606)28:6<385::AID-PROS8>3.0.CO;2-9. Prostate. 1996. PMID: 8650076

7

Relative and total volume of histological components in benign prostatic hyperplasia: relationships between histological components and clinical findings.

Ishigooka M, Hayami S, Hashimoto T, Suzuki Y, Katoh T, Nakada T. Ishigooka M, et al. Prostate. 1996 Aug;29(2):77-82. doi: 10.1002/(SICI)1097-0045(199608)29:2<77::AID-PROS2>3.0.CO;2-E. Prostate. 1996. PMID: 8700803

8

Norepinephrine contents of human prostatic hyperplasia: differences between pathological subtypes.

Ishigooka M, Hayami S, Tomaru M, Hashimoto T, Sasagawa I, Nakada T. Ishigooka M, et al. Int Urol Nephrol. 1996;28(1):61-6. doi: 10.1007/BF02550139. Int Urol Nephrol. 1996. PMID: 8738621

9

Age-related changes of histological composition in established benign prostatic hyperplasia.

Ishigooka M, Hayami S, Suzuki Y, Hashimoto T, Sasagawa I, Nakada T. Ishigooka M, et al. Eur Urol. 1996;29(1):85-9. doi: 10.1159/000473724. Eur Urol. 1996. PMID: 8821697

10

Correlations between parameters in uroflowmetry and histological compositions in patients with benign prostatic hyperplasia.

Ishigooka M, Hayami S, Hashimoto T, Suzuki Y, Sasagawa I, Nakada T. Ishigooka M, et al. Urol Int. 1996;57(1):48-50. doi: 10.1159/000282876. Urol Int. 1996. PMID: 8840491

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146 results

Search Page

Filters